ubmslateRN-logo-ubm

RN Mobile Menu

Search form

Topics:

Arthritis

Will You Buy In on the Next Biosimilar?

The FDA has deferred a scheduled meeting about Remsima, the infliximab biosimilar already approved in Europe and still awaiting judgment in the US. But approval of the first US biosimilar (a version of the cancer drug filgrastim) prompted warnings from two organizations concerned with rheumatic disease, including the ACR. Are you ready the next challenge to your clinical judgment?

Arthritis

© sergspb/Shutterstock.com

This modality may enhance the diagnostic workup of patients with early arthralgia at risk for inflammatory arthritis.

© Mike Focus/Shutterstock.com

Rheumatology leaders prescribe legislative fixes for drug cost and access issues.

For older adults in particular, managing the comorbidity as well as the arthritis is needed to attain improvement.

Cases have been reported in adults as well as in children who received this treatment.

MicroRNA collected in patients’ synovial fluid after treatment with antibiotics resembles that seen in chronic inflammatory states.

(Crohn's disease ©JuanGaertner/Shutterstock.com)

Inflammatory bowel disease patients can be afflicted by various forms of arthritis from peripheral arthritis to ankylosing spondylitis and symmetrical polyarthritis. In this slideshow, we address identification, diagnosis and treatment for these complex cases.

©thailoei92/shutterstock.com

A new study finds that low doses of fish oil improved pain and function in knee osteoarthritis more effectively than high doses. No clinical or structural advantage to an anti-inflammatory dose was found.

Pages

Subscribe to Arthritis on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.